JPS60156387A - ロダニン誘導体を有効成分とするアルド−ス還元酵素阻害剤 - Google Patents

ロダニン誘導体を有効成分とするアルド−ス還元酵素阻害剤

Info

Publication number
JPS60156387A
JPS60156387A JP25557684A JP25557684A JPS60156387A JP S60156387 A JPS60156387 A JP S60156387A JP 25557684 A JP25557684 A JP 25557684A JP 25557684 A JP25557684 A JP 25557684A JP S60156387 A JPS60156387 A JP S60156387A
Authority
JP
Japan
Prior art keywords
rhodanine
carboxymethyl
aldose reductase
active ingredient
reductase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP25557684A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6324974B2 (https=
Inventor
Tadao Tauchi
田内　忠男
Masanori Kawamura
川村　雅範
Akio Ashima
阿島　彰男
Tetsuya Mori
哲也 毛利
Masaki Hayashi
正樹 林
Hiroshi Terajima
寺島　宏
Fumio Hirata
平田　文雄
Takeshi Morimura
森村　武士
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Priority to JP25557684A priority Critical patent/JPS60156387A/ja
Publication of JPS60156387A publication Critical patent/JPS60156387A/ja
Publication of JPS6324974B2 publication Critical patent/JPS6324974B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP25557684A 1984-12-05 1984-12-05 ロダニン誘導体を有効成分とするアルド−ス還元酵素阻害剤 Granted JPS60156387A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP25557684A JPS60156387A (ja) 1984-12-05 1984-12-05 ロダニン誘導体を有効成分とするアルド−ス還元酵素阻害剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25557684A JPS60156387A (ja) 1984-12-05 1984-12-05 ロダニン誘導体を有効成分とするアルド−ス還元酵素阻害剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP55115641A Division JPS5740478A (en) 1980-08-22 1980-08-22 Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative

Publications (2)

Publication Number Publication Date
JPS60156387A true JPS60156387A (ja) 1985-08-16
JPS6324974B2 JPS6324974B2 (https=) 1988-05-23

Family

ID=17280634

Family Applications (1)

Application Number Title Priority Date Filing Date
JP25557684A Granted JPS60156387A (ja) 1984-12-05 1984-12-05 ロダニン誘導体を有効成分とするアルド−ス還元酵素阻害剤

Country Status (1)

Country Link
JP (1) JPS60156387A (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02124878A (ja) * 1988-11-02 1990-05-14 Kaken Pharmaceut Co Ltd チアゾリジン‐２，４‐ジオン誘導体およびその製造法
US5116855A (en) * 1989-05-19 1992-05-26 Nisshin Flour Milling Co., Ltd. Rhodanine derivatives and pharmaceutical compositions
WO2005026127A1 (ja) * 2003-09-11 2005-03-24 Institute Of Medicinal Molecular Design. Inc. プラスミノゲンアクチベータインヒビター－１阻害剤

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02124878A (ja) * 1988-11-02 1990-05-14 Kaken Pharmaceut Co Ltd チアゾリジン‐２，４‐ジオン誘導体およびその製造法
US5116855A (en) * 1989-05-19 1992-05-26 Nisshin Flour Milling Co., Ltd. Rhodanine derivatives and pharmaceutical compositions
WO2005026127A1 (ja) * 2003-09-11 2005-03-24 Institute Of Medicinal Molecular Design. Inc. プラスミノゲンアクチベータインヒビター－１阻害剤

Also Published As

Publication number Publication date
JPS6324974B2 (https=) 1988-05-23

Similar Documents

Publication Publication Date Title
US5225426A (en) Thiazolidine-2,4-dione compound and method of treatment of diabetic complications
WO2021218638A1 (zh) 用于糖尿病及其并发症治疗的联合用药及其药物组合物
KR100608416B1 (ko) 2-(ｎ-시아노이미노)티아졸리딘-4-온 유도체
US9492422B2 (en) Therapeutic or prophylactic agent for diabetes
CA2036375A1 (en) Heteroaryl-3-oxo-propanenitrile derivatives useful in stimulating myelopoiesis
JPS63270626A (ja) 抗潰瘍剤
JPS61286326A (ja) パ−キンソン病治療薬
JPS60156387A (ja) ロダニン誘導体を有効成分とするアルド−ス還元酵素阻害剤
AU657015B2 (en) The use of d-fenfluramine and fenfluramine compounds in the treatment of hypertension in insulin-resistant subjects
JPH06500537A (ja) アテローム硬化症の治療のためのアリールヒドロキシ尿素化合物の使用
JPH0352816A (ja) 腎炎の治療剤
WO2001052849A1 (en) Remedies for diabetes
JPH07506568A (ja) 糖尿病治療のための既存の薬剤の使用
RU2093155C1 (ru) Применение 5-[2-хлор-1-гидроксиэтил]-4-метилтиазола для снижения поражения нейронов, подавления конвульсий и снижения двигательной активности
EP0444546B1 (en) Hydantoin derivatives for use as hypoglycemic and/or hypolipidemic agents
JPH05504130A (ja) 腫瘍壊死因子拮抗剤
JPS6081127A (ja) 食欲抑制剤
KR100650278B1 (ko) 엔-아릴 엔' 모르폴리노/ 피페리디노 티오카르바마이드유도체를 유효성분으로 함유하는 당뇨병, 당뇨병 합병증,인슐린저항성 및 그로 인한 인슐린 저항성 증후군의 예방및 치료용 약학적 조성물
US3950538A (en) Anti-inflammatory methods utilizing certain thioureas
EP0455830B1 (en) Medicine containing thiazine dioxide derivative
JPH04503512A (ja) 新規な医薬用途
JP2003238407A (ja) ロイコトリエン産生抑制剤
DE68907433T2 (de) Verwendung von Dimetylheptylphenylbutanoylethanolamin bei der Behandlung von Hyperuricemie.
JPH06145058A (ja) 医薬組成物およびその製造方法
BE1004295A3 (fr) Utilisation des activateurs des canaux potassiques pour la prophylaxie de l'asthme.